 Potential value hormone receptor carcinoma situ breast estrogen receptor ER expression invasive breast cancer specific monoclonal antibodies ER studies ER pattern breast carcinoma situ CIS premalignant lesions current study authors pattern ER expression cases breast CIS component invasive cancer cases atypical hyperplasia Paraffin sections formalin-fixed breast tissue underwent enzyme pretreatment nuclear antigenic sites Breast tissues underwent estrogen immunocytochemical assay specific monoclonal antibodies Abbott Laboratory Chicago IL cases heterogeneity intensity staining percentage ER-positive cells attempt relation pattern ER expression nuclear pleomorphism type CIS results ER immunocytochemical assay positive nuclear staining ER CIS CIS invasive cancer atypical hyperplasias ER expression CIS invasive carcinoma cases study comedocarcinoma incidence negative ER expression types CIS significant nuclear pleomorphism significant difference ER tumor heterogeneity premalignant malignant lesions